← Back to Search

Other

EUS Fiducial Placement for Pancreatic Cancer

N/A

Waitlist Available

Research Sponsored by University of Southern California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial is looking at a new way to place markers on pancreas tumors during a minimally invasive surgery, in order to improve tumor visualization.

Who is the study for?

This trial is for adults with pancreatic cancer who are set to have surgery. They must be undergoing an endoscopic ultrasound as part of their pre-surgery evaluation and have tumors between 5mm-4cm in size. It's not for those with blood clotting issues, metal allergies, pregnancy, under 18 years old, or diagnosed with pancreatic lymphoma.Check my eligibility

What is being tested?

The study tests if placing tiny markers called fiducials into the tumor using a special needle during an endoscopic ultrasound helps surgeons see the tumor better during removal. This will be tried on 20 patients to see if it's feasible and useful for future larger studies.See study design

What are the potential side effects?

Potential side effects may include discomfort from the procedure, minor bleeding where the fiducial is placed, infection risk at the site of placement, and possible allergic reactions in individuals sensitive to metals.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Relative Ease of Detection of the Tumor with Fiducial

The Proportion of patients in which the fiducial was successfully placed/total patients in which fiducial attempted

Secondary outcome measures

Abdominal Pain

Trial Design

1Treatment groups

Experimental Treatment

Group I: Fiducial PlacementExperimental Treatment1 Intervention

EUS with Fiducial Placement into Tumor

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor

906 Previous Clinical Trials

1,596,137 Total Patients Enrolled

Media Library

EUS with Fiducial (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02863783 — N/A

Pancreatic Cancer Research Study Groups: Fiducial Placement

Pancreatic Cancer Clinical Trial 2023: EUS with Fiducial Highlights & Side Effects. Trial Name: NCT02863783 — N/A

EUS with Fiducial (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02863783 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts still ongoing for this clinical trial?

"Affirmative, clinicaltrials.gov reports that this scientific investigation is actively recruiting candidates. It was published on November 23rd 2016 and recently modified on November 16th 2021. 20 patients are needed at a single medical centre to complete the trial."

Answered by AI

Am I able to register for this medical experiment?

"A maximum of 20 participants are being sought for this clinical trial, all of whom must have cancer of the pancreas and be between 18-100 years old."

Answered by AI

Is the eligibility for this investigation limited to those aged 60 and above?

"The parameters for entry into this clinical trial require that potential participants fall between 18 and 100 years of age. In addition, there are 11 studies available specifically designed for minors and 580 trials created to help senior citizens."

Answered by AI

Is there a limit to how many participants can join this experiment?

"Affirmative. Per the information located on clinicaltrials.gov, this trial is currently searching for participants to join their study. First posted on November 23rd 2016 and most recently edited on November 16th 2021, it seeks 20 individuals from one centre."

Answered by AI

Recent research and studies

Gastrointestinal EndoscopyJournal

Eus-guided Gold Fiducial Insertion for Image-guided Radiation Therapy of Pancreatic Cancer: 50 Successful Cases Without Fluoroscopy

Park, Walter G., Brian M. Yan, Devin Schellenberg, Jeff Kim, Daniel T. Chang, Albert Koong, Cheryl Patalano, and Jacques Van Dam. 2010. “Eus-guided Gold Fiducial Insertion for Image-guided Radiation Therapy of Pancreatic Cancer: 50 Successful Cases Without Fluoroscopy”. Gastrointestinal Endoscopy. Elsevier BV. doi:10.1016/j.gie.2009.10.030.

Gastrointestinal EndoscopyJournal

Eus-guided Tattooing Before Laparoscopic Distal Pancreatic Resection (with Video)

Lennon, Anne Marie, Naeem Newman, Martin A. Makary, Barish H. Edil, Eun Ji Shin, Mouen A. Khashab, Ralph H. Hruban, et al.. 2010. “Eus-guided Tattooing Before Laparoscopic Distal Pancreatic Resection (with Video)”. Gastrointestinal Endoscopy. Elsevier BV. doi:10.1016/j.gie.2010.07.023.

Gastrointestinal EndoscopyJournal

Eus-guided Fine-needle Tattooing for Preoperative Localization of Early Pancreatic Adenocarcinoma

Farrell, James J., Andy Sherrod, and Dilip Parekh. 2009. “Eus-guided Fine-needle Tattooing for Preoperative Localization of Early Pancreatic Adenocarcinoma”. Gastrointestinal Endoscopy. Elsevier BV. doi:10.1016/j.gie.2008.03.1069.

clinicaltrials.govStudy